Back to search
FDAFDA · Food and drugs·Recall number D-0379-2021

Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10.

Published May 26, 2021 · Recall initiated: April 19, 2021

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
ASENAPINE
Manufacturer
SigmaPharm Laboratories LLC
Distributor
Nationwide in the US
UPC
0342794016103
Lot
Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card